P1.171. Salvage Esophagectomy Outcomes After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: A 45-Patients Indian Single-Center Experience
Esophageal Cancer: Surgical Treatment of Esophageal Cancer The SANO trial demonstrated non-inferior 2-year overall survival with active surveillance versus immediate surgery in patients achieving clinical complete response after neoadjuvant chemoradiotherapy (nCRT) for esophageal cancer, with ~40% eventual...